---
title: "Paediatric COVID-19 severity across SARS-CoV-2 variants in hospitalised children in South Africa: a retrospective cohort study"
id: "medrxiv-19-paediatric-covid-19-severity-across-sars-cov-2-variants-in-hospitalised"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-paediatric-covid-19-severity-across-sars-cov-2-variants-in-hospitalised"
content_type: "clinical_feed_article"
specialty: "Research Highlights"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.06.26357377v1?rss=1"
published_at: "2026-07-09T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Paediatric COVID-19 severity across SARS-CoV-2 variants in hospitalised children in South Africa: a retrospective cohort study
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-paediatric-covid-19-severity-across-sars-cov-2-variants-in-hospitalised
- **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.06.26357377v1?rss=1)
- **Published At:** 2026-07-09T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
The evolving epidemiology of COVID-19, driven by successive SARS-CoV-2 variants of concern (VOCs), has prompted ongoing evaluation of their impact on disease severity in children. In low- and middle-income countries (LMICs), children experience a higher burden of severe respiratory illness and pneumonia-related mortality due to factors such as malnutrition, incomplete immunisation, HIV exposure or infection, tuberculosis, and disparities in access to healthcare services. Hospital-based paediatric studies from LMICs are therefore needed to understand how the epidemiology and severity of COVID-19 have changed across pandemic waves. This study examined 354 hospitalised children with SARS-CoV-2 infection during the ancestral, pre-Omicron (Beta and Delta), and Omicron waves at Tygerberg Hospital in Cape Town, South Africa. We analysed data collected over an extended period, from March 2020 to June 2022. Statistical analyses were used to describe clinical characteristics across variant periods, and multivariable logistic regression models were applied to evaluate associations between potential risk factors and disease severity. Paediatric COVID-19 severity varied across VOC periods, with the highest burden observed during the pre-Omicron (Beta and Delta) waves.
## Clinical Analysis & Structured Key Points
medRxiv (Clinical Preprints) published a clinical update in Research Highlights on 09 Jul 2026. The item focuses on Paediatric COVID-19 severity across SARS-CoV-2 variants in hospitalised children in South Africa: a retrospective cohort study. Review the original article for the full source wording and details.
## Related Clinical Research

- [Key drivers of future tuberculosis declines in South Africa: uncertainty analysis of testing, cont](https://medichelpline.com/clinical-feed/pubmed-42609173.md) (DOI: 10.1080/16549716.2026.2710936)
- [Tuberculosis screening and tuberculin skin test performance in adults with inborn errors of immuni](https://medichelpline.com/clinical-feed/frontiers-in-immunology-11-tuberculosis-screening-in-adult-patients-with-inborn-errors-of-immunity-a.md)
- [Beyond isolated cough events: AI-based tuberculosis screening through temporal analysis of cough sounds](https://medichelpline.com/clinical-feed/medrxiv-12-beyond-isolated-cough-events-ai-based-tuberculosis-screening-through-temporal.md)
- [Predicting radiological severity of pulmonary tuberculosis in children: an assessment of the WHO-criteria and novel prediction scores on an individual participant dataset](https://medichelpline.com/clinical-feed/medrxiv-2-predicting-radiological-severity-of-pulmonary-tuberculosis-in-children-an.md)
- [Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial](https://medichelpline.com/clinical-feed/nature-0-bispecific-10e8-4-imab-broadly-neutralizing-antibody-in-people-with-or-without.md)

## Navigation
- [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.